| 纳络酮治疗急性心肌梗塞并心源性休克18例临床观察 |
| |
| 引用本文： | 汪莲开,黄华. 纳络酮治疗急性心肌梗塞并心源性休克18例临床观察[J]. 湖北民族学院学报(医学版 ), 2001, 18(3): 12-13 |
| |
| 作者姓名： | 汪莲开 黄华 |
| |
| 作者单位： | 湖北省恩施市中心医院心内科, |
| |
| 摘 要： | 目的：了解纳络酮在心急性心肌梗塞（AMI）并心源性休克中的作用及对其预后的影响。方法：收集我院近4年来AMI并发心源性休克的患者35例，随机分普通组17例和纳络酮组18例进行救治，结果：常规组有效率为29．4％，纳络酮组有效率为61．1％，经x^2检验，P＜0．05，有显著性差异，结论：AMI并心源性休克在无条件实施急诊血运重建术的医院，在常规治疗的基础上加用纳络酮治疗，可显著提高有效率，降低死亡率。
|
| 关 键 词： | 急性心肌梗塞 并发症 休克 纳络酮 |
| 文章编号： | 1008-8164(2001)03-0012-02 |
| 修稿时间： | 2001-06-15 |
Clinical Observation of 18 AMI and Cardigenic Shock Patients Treated with Naloxon |
| |
| WANG Lian-kai,HUANG Hua. Clinical Observation of 18 AMI and Cardigenic Shock Patients Treated with Naloxon[J]. Journal of Hubei Institute For Nationalities(Medical Edition), 2001, 18(3): 12-13 |
| |
| Authors: | WANG Lian-kai HUANG Hua |
| |
| Abstract: | Objective To explore the effect of Naloxon in treating AMI and Cardigenic shock patients and its influence on future anticipation. Methods 35 cases during the last 4 years were collected and randomly divided into normal group (17 cases) and Naloxon group (18 cases) to receive respective treatment. Results The effective rate of Naloxon group was 61.5% and that of Normal group 29.4% ( P <0.05) Obvious difference existed.Conclusion Naloxon plus normal treatinent Can improve the effoctive rate and cut down the death rate remarkably of AMI and cardigenic shock patients in hospitals without condition to carry out anurgent operation to rebuild the route blood circulation. |
| |
| Keywords: | AMI/complication cardigenic schock naloxdn/therapy application |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
